Digital Sponsored AI-enabled pharmacovigilance, with Updesh Dosanjh Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.
Patients Why patient safety doesn't end at approval Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.
Patients Why Britain's blood tests are only as reliable as the journe... What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned
Sales & Marketing Why trust is becoming pharma’s most important visibility met... Any gap between an AI-generated answer and a product’s approved profile carries consequences for prescribing decisions and patient safety.
Market Access Fighting fake GLP-1s to protect patients & preserve trust Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.
Patients Every child deserves safe care from day one Patient safety remains one of the most pressing global health challenges of our time.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.